The Relationship between Long suffering and medication adherence with Quality-of-Life in Patients with Type 2 Diabetes Mellitus

Authors

  • Dyan Kunthi Nugrahaeni Master of Public Health Study Program, Faculty of Health Science and Technology, Jenderal Achmad Yani University, Cimahi, West Java, Indonesia
  • Novie Elvinawaty Mauliku Master of Public Health Study Program, Faculty of Health Science and Technology, Jenderal Achmad Yani University, Cimahi, West Java, Indonesia
  • Teguh Akbar Budiana Public Health Study Program, Faculty of Health Science and Technology, Jenderal Achmad Yani University, Cimahi, West Java, Indonesia

DOI:

https://doi.org/10.29084/isgh.v6i1.509

Keywords:

type 2 diabetes mellitus, long suffering, medication adherence

Abstract

Type 2 diabetes mellitus (T2DM) is a long-term condition that cannot be completely cured, it can affect health and quality of life (QOL). This study aims to determine the relationship between long suffering and medication adherence with quality of life among patients with T2DM. Research design used cross sectional study, samples are patients with T2DM at Cibereuem and Cigugur Tengah Public Health Center, Cimahi West Java, as many as 115 patients. The independent variables were long suffering measures in years since diagnosis, medication adherence using MMAS-8, while the dependent variable is QOL for diabetes used the Diabetes Quality of Life-Brief Clinical Inventory (DQOL-BCI). Data analysis using chi-square, the p-value was as a significant test, with a significance level (alpha)=0.05. The result of this study showed that the variables were significant with quality-of-life patient T2DM are long suffering (p value= 0.01; OR= 3.54, (5%CI: 1.40-8.92), medication adherence (p value= 0.01; OR= 3.54, (5%CI: 1.40-8.92). The results highlight the importance of addressing long-term illness duration and promoting adherence to medication to enhance patients’ quality of life. Interventions targeting patients with T2DM who have been living with the disease for more than five years should focus on improving medication adherence to achieve better QOL outcomes.

Downloads

Published

2026-02-01